<DOC>
	<DOCNO>NCT03103191</DOCNO>
	<brief_summary>KL-6 may useful biomarker patient interstitial lung disease , limited information non-Asian population . Therefore , necessary carry study population confirm diagnostic value biomarker prognostic implication . Hypothesis KL-6 may useful biomarker management interstitial lung disease . But necessary know utility European population . Study Objectives : - To determine concentration KL-6 serum patient pulmonary fibrosis time diagnosis compare patient without pulmonary fibrosis - Diagnostic yield KL-6 patient pulmonary fibrosis . - Correlation KL-6 value functional radiological parameter disease severity diagnosis . - Correlation serum KL-6 value evolution disease .</brief_summary>
	<brief_title>Diagnostic Value KL-6 ILD</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>1 . Subjects older 18 year . 2 . Chronic respiratory disease ) include Fibrotic interstitial lung disease , asthma COPD ) relate connective tissue disease . 3 . Acceptance patient participate study signing inform consent discuss researcher objective , risk potential benefit . 1 . Absence inform consent 2 . Psychiatric disorder limitation collaboration ( include language , sociocultural problem , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>